logo
logo

Complement Therapeutics Ltd Raises Eur 5 Million Seed Financing By Bgv And Forbion And Appoints Dr Rafiq Hasan As Ceo

Complement Therapeutics Ltd Raises Eur 5 Million Seed Financing By Bgv And Forbion And Appoints Dr Rafiq Hasan As Ceo

02/23/22, 3:00 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/CA.svglondon
Money raised
€5 million
Round Type
seed
Complement Therapeutics Ltd (CTx), a preclinical stage University of Manchester spinout, announced today the completion of its EUR 5 million seed financing round from BioGeneration Ventures (BGV) and Forbion, two leading European venture capital firms. BGV provided the initial seed-funding in early 2021 with both Forbion and BGV now investing additional seed financing.

Company Info

Company
Complement Therapeutics Ltd
Location
london, ontario, canada
Additional Info
The company also announces today the appointments of two highly experienced industry executives, Dr Rafiq Hasan as Chief Executive Officer and Dr John Ford as an independent director.